Skip to main content
In stock | Targeted Therapy (Investigational)

Pelabresib

Oncology Type Hematologic (MPN)
Drug Class / Mechanism BET Bromodomain Inhibitor
No Image
Description

Pelabresib is classified as a BET Bromodomain Inhibitor, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Investigational)
Oncology Type Hematologic (MPN)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3